This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Retain RenaissanceRe Stock for Now
by Zacks Equity Research
RNR's premium growth, acquisitions, strong cash returns and undervaluation support its stock despite rising costs and debt pressure.
Synchrony Teams Up With Audibel to Expand Financing for Hearing Care
by Zacks Equity Research
SYF partners with Audibel to expand CareCredit and installment financing for hearing care across 1,000+ locations.
Buy 5 Stocks to Stay Safe in Wall Street's Historically Worst Month
by Nalak Das
September's market jitters make low-beta, high-yield picks like AIZ, HAS, MOS, VIRT and HLI smart defensive bets.
Here is Why Growth Investors Should Buy Houlihan Lokey (HLI) Now
by Zacks Equity Research
Houlihan Lokey (HLI) could produce exceptional returns because of its solid growth attributes.
Best Momentum Stock to Buy for August 4th
by Zacks Equity Research
ZWS, LC and HLI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 4, 2025.
New Strong Buy Stocks for August 4th
by Zacks Equity Research
CLS, SBFG, HTB, HLI and UDMY have been added to the Zacks Rank #1 (Strong Buy) List on August 4, 2025.
Houlihan Lokey (HLI) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Houlihan Lokey (HLI) delivered earnings and revenue surprises of +26.63% and +2.85%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
COIN to Report Q2 Earnings: Will Higher Trading Volume Fuel Growth?
by Zacks Equity Research
COIN's Q2 results may get a lift from surging trading volumes, rising crypto prices and gains in U.S. derivatives markets.
Virtu Financial (VIRT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Virtu Financial (VIRT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Servicing Revenues Slump Looms, Can Rithm Capital Still Deliver in Q2?
by Zacks Equity Research
RITM is likely to register lower servicing and asset management revenues in Q2. Can it still deliver an earnings beat?
Houlihan Lokey (HLI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Houlihan Lokey (HLI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in StepStone Group (STEP): Can Its 6.0% Jump Turn into More Strength?
by Zacks Equity Research
StepStone Group (STEP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why Houlihan Lokey (HLI) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Houlihan Lokey (HLI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for OUSM
Houlihan Lokey Shares Up Since Q4 Earnings Beat Estimates
by Zacks Equity Research
HLI shares climb 5.4% after Q4 earnings beat, driven by strong segment growth and higher revenues despite rising expenses.
Houlihan Lokey (HLI) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Houlihan Lokey (HLI) delivered earnings and revenue surprises of 21.74% and 6.42%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Royalty Pharma (RPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FinWise Bancorp (FINW) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
FinWise Bancorp (FINW) delivered earnings and revenue surprises of -8% and 2.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Houlihan Lokey (HLI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Houlihan Lokey (HLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for OUSM
Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for OUSM
Looking for a Growth Stock? 3 Reasons Why Houlihan Lokey (HLI) is a Solid Choice
by Zacks Equity Research
Houlihan Lokey (HLI) could produce exceptional returns because of its solid growth attributes.
3 Reasons Why Houlihan Lokey (HLI) Is a Great Growth Stock
by Zacks Equity Research
Houlihan Lokey (HLI) possesses solid growth attributes, which could help it handily outperform the market.
Houlihan Lokey (HLI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Houlihan Lokey (HLI) delivered earnings and revenue surprises of 8.61% and 7.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Lazard (LAZ) Q4 Earnings Expected to Decline
by Zacks Equity Research
Lazard (LAZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.